Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-10-10
2006-10-10
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S070200, C530S387100, C530S388100
Reexamination Certificate
active
07118889
ABSTRACT:
The invention generally relates to compositions and methods for identifying and testing tyrosine kinase signaling pathway agonists and antagonists, and more particularly, methods and compositions for screening compounds and identifying compounds that will modulate the interaction of protein tyrosine kinase substrates with their intracellular ligands, as well as between their intracellular ligands and other members of the signaling pathway.
REFERENCES:
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 4018653 (1977-04-01), Mennen
patent: 4424279 (1984-01-01), Bohn et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 5608039 (1997-03-01), Pastan et al.
patent: 5652096 (1997-07-01), Cimino
patent: 6180370 (2001-01-01), Queen et al.
Roitt et al. Immunology, third edition., Mosby, St. Louis, pp. 6.4 and 6.5, 1993.
Weiss et al., “Signal transduction by lymphocyte antigen receptors,”Cell76:263-274 (1994).
Cantrell, “T Cell Antigen Receptor Signal Transduction Pathways,”Annu. Rev. Immunol., 14:259-274 (1996).
Marmur and Lane, “Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Biological Studies,”Proc. Natl. Acad. Sci. USA46:453 (1960).
Doty et al., “Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Physical Chemical Studies,”Proc. Natl. Acad. Sci. USA46:461 (1960).
Wallace et al., (1985) “Application of synethetic oligonucleotides to the diagnosis of human genetic diseases,”Biochimie67:755-762.
Studencki and Wallace, “Allele-Specific Hybridization Using Olignucleotide Probes of Very High Specific Activity: Discrimination of the Human βA—and βS-Globin Genes,”DNA3:7-15 (1984).
Studencki et al., (1985) “Discrimination Among the Human, βA, βS, and βC-Globin Genes Using Allele-Specific Oligonucleotide Hybridization Probes,”Human Genetics37:42-51.
Smith and Waterman, “Comparison of Biosequences,”Adv. Appl. Math.2:482-489 (1981).
Needleman and Wunsch, “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins,”J. Mol. Biol.48:443-453 (1970).
Pearson and Lipman, “Improved Tools for Biological Sequence Comparison,”Proc. Natl. Acad. Sci. USA85:2444 (1988).
Exley et al., “Association of phosphatidylinositol-3-kinase with a specific sequence of the T cell receptor chain is dependent on T cell activation,”J. Biol. Chem.269:15140-15146 (1994).
Cambier et al., “Differential binding activity of ARH1/TAM motifs,”Immunol. Lett.44:77-80 (1995).
Isakov et al., “ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity,”J. Exp. Med.181:375-380 (1995).
Osman et al., “The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor subunits and the CD3, and chains,”Eur. J. Immunol.26:1063-1068 (1996).
Caplan et al., “Cell-surface expressed T-cell antigen-receptor chain is associated with the cytoskeleton,”Proc. Natl. Acad. Sci. USA92:4768-4772 (1995).
Rozdzial et al., Tyrosine-phosphorylated T cell receptor chain associates with actin cytoskeleton upon activation of mature T lymphocytes,Immunity3:623-633 (1995).
Bolen et al., “Nonreceptor tyrosine protein kinases,”Oncogene8:2025-2031 (1993).
Peri et al., “Tyrosine protein kinases in T lymphocytes,”Chem. Immunol.59:19-39 (1994).
Jayaraman et al., “Regulation of the Inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation,”Science272:1492-1494 (1996).
Cheng et al., “Syk tyrosine kinase required for mouse viability and B-cell development,”Nature378:303-306 (1995).
Fargnoli et al., “Syk mutation in Jurkat E6-derived clones results in lack of p72syk expression,”J Biol. Chem.270:26533-26537 (1995).
Turner et al., “Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk,”Nature378:298-302 (1995.
Arpaia et al., “Defective T cell receptor signaling and CD8+ thymic selection in humans lacking ZAP-70 kinase,”Cell76:947-958 (1994).
Chan et al., “ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency,”Science264:1599-1601 (1994).
Elder et al., “Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase,”Science264:1596-1599 (1994).
Negishi et al., “Essential role for ZAP-70 in both positive and negative selection of thymocytes,”Nature376:435-438 (1995).
Chan et al., “ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR ζ chain,”Cell71:649-662 (1992).
Watts et al., “Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70,”J. Biol. Chem.269:29520-29529 (1994).
Guanghui et al. “Distinct tyrosine phosphorylation sites within ZAP-70 mediate activation and negative regulation of antigen receptor function,”Mol. Cell. Biol.(1996).
Chan et al., “Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function,”EMBO J.14:2499-2508 (1995).
Wange et al., “Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70,”J. Biol. Chem.270:18730-18733 (1995).
Wange et al., “Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor and CD3 from activated Jurkat T cells,”J. Biol.Chem.268:19797-19801 (1993).
Iwashima et al., “Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases,”Science263:1136-1139 (1994).
Wange et al., “F2(Pmp)2-TAM 3, a novel competitive inhibitor of the binding of ZAP-70 to the T cell antigen receptor, blocks early T cell signaling,”J. Biol. Chem.270:944-948 (1995).
Qian et al., “Dominant-negative Zeta-associated Protein 70 Inhibits T Cell Antigen Receptor Signaling,”J. Exp. Med.183:611-620 (1996).
van Oers et al., “Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR ζ,”Mol. Cell. Biol.13:5771-5780 (1993).
Wiest et al., “TCR activation of ZAP-70 is impaired in CD4+CD8+ thymocytes as a consequence of intrathymic interactions that diminish available p56lck,”Immunity4:495-504 (1996).
Desiderio et al., “The Itk/Btk/Tec Family of Protein-Tyrosine Kinases,”Chem. Immunol.59:191-208 (1994).
Liao et al., “Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk,”Immunity3:757-769 (1995).
Gibson et al., “The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling,”J. Immunol.156:2716-2722 (1996).
Bustelo et al., “Product of the Vav protooncogene defines a new class of tyrosine protein kinase substrates,”Nature356: 68-74 (1992).
Donovan et al., “The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor,”J. Biol. Chem.269:22921-22924 (1994).
Jackman et al., “Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells,”J. Biol. Chem.270:7029-7032 (1995).
Harrison et al., “Phosphorylation of human erythrocyte band 3 by endogenous p72syk,”J. Biol. Chem.269:955-959 (1994).
Peters et al., “Syk, activated by cross-linking the B-cell antigen receptor, localizes to the cytosol where it interacts with and phosphorylates alpha-tubulin on tyrosine,”J. Biol. Chem.271:4755-4762 (1996).
Ley et al., “Tyrosine p
Samelson Lawrence E.
Zhang Weiguo
Corless Peter F.
Edwards Angell Palmer & & Dodge LLP
Helms Larry R.
Rucker, Esq. Susan S.
The United States of America as represented by the Department of
LandOfFree
Protein tyrosine kinase substrate LAT and its use in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein tyrosine kinase substrate LAT and its use in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein tyrosine kinase substrate LAT and its use in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3660510